CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About CADTH What We Do Programs and Services CADTH Common Drug Review Reports Voriconazole

Voriconazole

Last Updated: August 24, 2004

Result type: Reports

Project Number: S0020

Product Line: Common Drug Review

Generic Name: Voriconazole

Brand Name: VFEND

Manufacturer: Pfizer Canada Inc.

Indications: Aspergillosis, Invasive

Submission Type: New

Project Status: Withdrawn

Voriconazole

Files